BioSpace News Archive

Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in IsraelInternational Markets Show Immediate and Increasing Demand for FDA-Cleared, CE Mark-Approved NeuroCap Device

Brain Scientific (OTCQB:BRSF), a Florida-based applied science technology company, today announces a new distribution agreement with SysteMedic to meet market demand. Brain Scientific is targeting the pediatric and ICU markets for the NeuroCap in hospitals.

January 26, 2023
·
4 min read
Business

Sartorius with clear double-digit growth in fiscal 2022

Following extraordinary growth in 2020 and 2021, the life science group Sartorius again outperformed the market in fiscal 2022, achieving its targets for sales revenue and profitability.

January 26, 2023
·
13 min read
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

SN BioScience and Boryeong signed a domestic manufacturing technology transfer and co-development contract for the albumin nanoparticle anticancer drug developed by SN BioScience for the first time in Korea and the fourth time in the world.

January 26, 2023
·
3 min read
Business

Preliminary results 2022 of Sartorius Stedim Biotech

Following extraordinary growth in 2020 and 2021, Sartorius Stedim Biotech, a leading partner of the biopharma industry, again outperformed the market in fiscal 2022.

January 26, 2023
·
11 min read
Business

Report on Operations 2022

Net sales amounted to SEK 131.5 million (85.9), corresponding to an increase of 53 percent in SEK and 34 percent adjusted for currency effects. Organic growth accounted for 27 percent and acquired growth for 7 percent.

January 26, 2023
·
5 min read
Esaote presents the world premiere of its new MyLab™X90 ultrasound device

Today Esaote, a leading Italian company in the biomedical sector – in ultrasound, dedicated MRI and medical IT– presents the world premiere of MyLab™X90, its new premium ultrasound system.

January 26, 2023
·
3 min read
Business

Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment

Nogra Pharma today announces it has entered into an out-licensing agreement with Torii Pharmaceutical Co., Ltd. (Torii) (TSE:4551), to further develop and commercialise NAC-GED-0507 in Japan for the treatment of acne vulgaris.

January 26, 2023
·
5 min read
Bio NC

BioCryst Begins Enrollment in Pivotal APeX-P Trial Evaluating ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the enrollment of the first patient in the pivotal APeX-P trial evaluating oral, once-daily ORLADEYO ® (berotralstat) in pediatric hereditary angioedema (HAE) patients who are 2 to12 years of age.

January 26, 2023
·
7 min read
Bio NC

RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease

RedHill Biopharma Ltd. today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the granting of a patent covering RHB-204’s1 oral fixed-dose combination.

January 26, 2023
·
11 min read
Grey Wolf Therapeutics Closes Oversubscribed $49 Million Series B Financing to Advance First-of-its-Kind Neoantigen Creation Approaches

Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer neoantigen creation, today announced the closing of an oversubscribed $49 million Series B financing.

January 26, 2023
·
5 min read